Search
First Trust Nasdaq Pharmaceuticals ETF
FTXHAdd to Watchlist
43.430USD
+0.299+0.69%
Close 11-06 16:00（ET）
2.00KVolume
86.67KTurnover
Today
+0.69%
5 Days
-1.83%
1 Month
+6.77%
6 Months
+28.07%
Year to Date
+32.44%
1 Year
+45.21%
Key Figures
42.690Open
43.131Prev. Close
43.620High
42.450Low
2.00KVolume
86.67KTurnover
0.02Volume Ratio
45.10052wk High
29.94852wk Low
94.32KAvg Volume
0.72%Div Yield
0.290Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
42.653NAV
USDNAV Currency
4.80P/B
21.62Price to earnings ratio
First Trust Nasdaq Pharmaceuticals ETF Profile
Ticker SymbolFTXH
Asset ClassEquity
Fund ManagerFirst Trust
DomicileUS
Expense Ratio0.60%
Founded at2016-09-20
Tracking IndexNasdaq US Smart Pharmaceuticals Index
FTXH was created on 2016-09-20 by First Trust. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 1092.83m in AUM and 51 holdings. FTXH tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
AbbVie Inc
ABBV
291.310
+3.070
+1.07%
309.25K
7.75%
$88.34M
Eli Lilly and Co
LLY
1354.000
-10.730
-0.79%
68.55K
7.65%
$87.30M
Pfizer Inc
PFE
29.390
-0.060
-0.20%
2.79M
7.34%
$83.67M
4
Johnson & Johnson
JNJ
276.220
+3.900
+1.43%
298.30K
6.90%
$78.69M
5
Merck & Co Inc
MRK
146.730
-0.210
-0.14%
536.67K
6.84%
$77.96M
6
Biogen Inc
BIIB
248.350
+4.420
+1.81%
183.01K
4.02%
$45.88M
7
Viatris Inc
VTRS
19.910
+0.940
+4.96%
2.40M
3.79%
$43.23M
8
Gilead Sciences Inc
GILD
166.890
-0.680
-0.41%
270.93K
3.71%
$42.28M
9
Zoetis Inc Class A
ZTS
79.400
-2.710
-3.30%
514.26K
3.65%
$41.67M
10
United Therapeutics Corp
UTHR
562.020
-3.700
-0.65%
68.97K
3.55%
$40.52M
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy
First Trust Nasdaq Pharmaceuticals ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of First Trust Nasdaq Pharmaceuticals ETF (FTXH)?
The current price of First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 43.43. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of First Trust Nasdaq Pharmaceuticals ETF?
The 52-week high of First Trust Nasdaq Pharmaceuticals ETF is 45.10. Please refer to the page timestamp for the latest data.
What is the 52-week low of First Trust Nasdaq Pharmaceuticals ETF?
The 52-week low of First Trust Nasdaq Pharmaceuticals ETF is 29.95. Please refer to the page timestamp for the latest data.
What is the NAV of First Trust Nasdaq Pharmaceuticals ETF?
The NAV of First Trust Nasdaq Pharmaceuticals ETF is 42.65 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is First Trust Nasdaq Pharmaceuticals ETF (FTXH) performing?
The trading turnover of First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 86.67K. Its price changed by 5.29% over the past month, while its one-year return is 44.06%. View the First Trust Nasdaq Pharmaceuticals ETF price chart for more details.
Is First Trust Nasdaq Pharmaceuticals ETF (FTXH) a safe investment?
No investment is completely risk-free. The risk level of First Trust Nasdaq Pharmaceuticals ETF (FTXH) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.